NOVONESIS A/S (NOVOZYMES A/S) revenue breakdown overview

NOVONESIS A/S (NOVOZYMES A/S) revenue for the last year amounted to 3.89 B EUR, the most of which — 2.26 B EUR — came from its highest performing source at the moment, Planetary Health Biosolutions. The greatest contribution to the revenue figure was made by Rest of Europe, Middle East & Africa — last year it brought NOVONESIS A/S (NOVOZYMES A/S) 1.40 B EUR, and the year before that — 789.15 M EUR.